Crossmark Global Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.92M Buy
2025
Q1
$914K Buy
2024
Q4
$848K Sell
2024
Q3
$937K Buy
2024
Q2
$909K Buy
2023
Q2
Sell
2023
Q1
$207K Buy
2022
Q4
$209K Buy
2018
Q4
Sell
2018
Q3
$506K Sell
2018
Q2
$499K Sell
2018
Q1
$474K Sell
2017
Q4
$686K Buy
2017
Q3
$695K Buy
2016
Q3
$695K Buy